Literature DB >> 17415564

Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Futoshi Anan1, Takayuki Masaki, Hidetoshi Yonemochi, Naohiko Takahashi, Mikiko Nakagawa, Nobuoki Eshima, Tetsunori Saikawa, Hironobu Yoshimatsu.   

Abstract

PURPOSE: We tested the hypothesis that increased abdominal visceral accumulation (VFA) is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.
METHODS: The fat distribution was evaluated by measuring the VFA by abdominal computed tomography at the umbilical level. The study group consisted of 24 type 2 diabetic patients with high VFA (> or =100 cm(2), age 60 +/- 8 years, high VFA group). The control group consisted of 19 age-matched type 2 diabetic patients with normal VFA (<100 cm(2), age 60 +/- 7 years, normal VFA group). Cardiovascular autonomic function was assessed by baroreflex sensitivity, heart rate variability, plasma norepinephrine concentrations, and cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphy.
RESULTS: Early and delayed (123)I-MIBG myocardial uptake values were lower (p < 0.005 and p < 0.0001, respectively) and the percent washout rate of (123)I-MIBG was higher (p < 0.0005) in the high VFA group than in the normal VFA group. The fasting plasma insulin concentrations (p < 0.005) and the homeostasis model assessment (HOMA) index values (p < 0.0005) were higher in the high VFA group than in normal VFA group. Multiple regression analysis revealed that the level of VFA was independently predicted by the HOMA index values and the myocardial uptake of (123)I-MIBG during the delayed phase.
CONCLUSION: Our results demonstrate that the level of VFA is associated with depressed cardiovascular autonomic function and insulin resistance in patients with type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415564     DOI: 10.1007/s00259-007-0421-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  48 in total

1.  Abdominal fat: standardized technique for measurement at CT.

Authors:  T Yoshizumi; T Nakamura; M Yamane; A H Islam; M Menju; K Yamasaki; T Arai; K Kotani; T Funahashi; S Yamashita; Y Matsuzawa
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation.

Authors:  L Benthem; K Keizer; C H Wiegman; J H Strubbe; A B Steffens; F Kuipers; A J Scheurink
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-12       Impact factor: 4.310

3.  Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-17       Impact factor: 9.236

4.  Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Authors:  Futoshi Anan; Hidetoshi Yonemochi; Takayuki Masaki; Naohiko Takahashi; Mikiko Nakagawa; Nobuoki Eshima; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-04       Impact factor: 9.236

5.  Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.

Authors:  J B Meigs; P F Jacques; J Selhub; D E Singer; D M Nathan; N Rifai; R B D'Agostino; P W Wilson
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

6.  Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.

Authors:  G Targher; L Bertolini; L Scala; G Zoppini; L Zenari; G Falezza
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

7.  Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.

Authors:  A G Kontopoulos; V G Athyros; T P Didangelos; A A Papageorgiou; M J Avramidis; M C Mayroudi; D T Karamitsos
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

8.  Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients.

Authors:  N Takahashi; M Nakagawa; T Saikawa; T Ooie; K Yufu; S Shigematsu; M Hara; H Sakino; I Katsuragi; T Okeda; H Yoshimatsu; T Sakata
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

9.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

Authors:  H Tsuji; M G Larson; F J Venditti; E S Manders; J C Evans; C L Feldman; D Levy
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

10.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

View more
  4 in total

1.  Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Victoria Delgado; Jurriaan A Kok; Mieke T J Bus; Arie C Maan; Marcel P Stokkel; Antje V Kharagitsingh; Petra Dibbets-Schneider; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-22       Impact factor: 9.236

2.  Role of interleukin-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients.

Authors:  Tetsuji Shinohara; Naohiko Takahashi; Kunio Yufu; Futoshi Anan; Tetsuya Kakuma; Masahide Hara; Mikiko Nakagawa; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-01       Impact factor: 9.236

3.  Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity.

Authors:  N E Straznicky; L Guo; S J Corcoran; M D Esler; S E Phillips; C I Sari; M T Grima; S Karapanagiotidis; C Y Wong; N Eikelis; J A Mariani; D Kobayashi; J B Dixon; G W Lambert; E A Lambert
Journal:  Obes Sci Pract       Date:  2016-01-19

4.  Visceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes.

Authors:  Daisuke Murakami; Futoshi Anan; Takayuki Masaki; Yoshikazu Umeno; Takehiko Shigenaga; Nobuoki Eshima; Takashi Nakagawa
Journal:  J Diabetes Res       Date:  2019-05-02       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.